AUTL
USDAutolus Therapeutics plc American Depositary Share
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.370
Kõrge
$2.370
Madal
$2.210
Maht
0.19M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
596.1M
Tööstusharu
Biotehnoloogia
Riik
United Kingdom
Kauplemisstatistika
Keskmine maht
2.19M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Autolus Therapeutics with a Buy and maintains $10 price target.
Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
Median duration of response in FELIX study now 42.6 months after an additional 11 months of follow upMore than half of patients still in remission at 24 months38% of ongoing responders did not receive any subsequent
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicityOpinion follows FDA approval and
Seotud aktsiad
ZOM
Zomedica Corp. Common Shares
CLOV
Clover Health Investments Corp.
GHSI
Guardion Health Sciences Inc.
SGRY
Surgery Partners Inc.
IINN
Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.